EXICURE, INC. Operating Cash Flow
EXICURE, INC. (XCUR) reported Operating Cash Flow of -$2.03 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-14
- EXICURE, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$887.00K.
- EXICURE, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$1.14M.
- EXICURE, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$1.15M.
- EXICURE, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$3.53M.
- EXICURE, INC. net cash provided by (used in) operating activities for fiscal 2025 was -$8.55M.
- EXICURE, INC. net cash provided by (used in) operating activities for fiscal 2024 was -$2.91M.
- EXICURE, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$10.36M.
- EXICURE, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$35.66M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$887.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$2.03M 10-Q · filed 2026-08-14 | -$3.18M derived: sum of 3 quarters · filed 2026-08-14 | -$6.70M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | -$1.14M 10-Q · filed 2026-05-29 | -$2.29M derived: sum of 2 quarters · filed 2026-05-29 | -$5.82M derived: sum of 3 quarters · filed 2026-05-29 | -$8.10M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | -$1.15M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$4.67M derived: sum of 2 quarters · filed 2026-03-25 | -$6.96M derived: sum of 3 quarters · filed 2026-08-14 | -$8.55M 10-K · filed 2026-03-25 |
| 2025-09-30 | -$3.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$5.81M derived: sum of 2 quarters · filed 2026-08-14 | -$7.41M 10-Q · filed 2025-11-07 | -$8.25M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$2.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$3.88M 10-Q · filed 2026-08-14 | -$4.72M derived: sum of 3 quarters · filed 2026-08-14 | -$5.17M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$1.60M 10-Q · filed 2026-05-29 | -$2.44M derived: sum of 2 quarters · filed 2026-05-29 | -$2.89M derived: sum of 3 quarters · filed 2026-05-29 | -$4.06M derived: sum of 4 quarters · filed 2026-05-29 |
| 2024-12-31 | -$845.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$1.29M derived: sum of 2 quarters · filed 2026-03-25 | -$2.46M derived: sum of 3 quarters · filed 2026-03-25 | -$2.91M 10-K · filed 2026-03-25 |
| 2024-09-30 | -$449.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$1.61M derived: sum of 2 quarters · filed 2025-11-07 | -$2.06M 10-Q · filed 2025-11-07 | -$2.88M derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-06-30 | -$1.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$1.62M 10-Q · filed 2025-08-08 | -$2.43M derived: sum of 3 quarters · filed 2025-08-08 | -$3.84M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | -$450.00K 10-Q · filed 2025-06-27 | -$1.27M derived: sum of 2 quarters · filed 2025-06-27 | -$2.68M derived: sum of 3 quarters · filed 2025-06-27 | -$7.49M derived: sum of 4 quarters · filed 2025-06-27 |
| 2023-12-31 | -$816.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | -$2.23M derived: sum of 2 quarters · filed 2025-03-18 | -$7.04M derived: sum of 3 quarters · filed 2025-03-18 | -$10.36M 10-K · filed 2025-03-18 |
| 2023-09-30 | -$1.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$6.22M derived: sum of 2 quarters · filed 2024-11-14 | -$9.54M 10-Q · filed 2024-11-14 | -$16.82M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | -$4.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$8.13M 10-Q · filed 2024-08-13 | -$15.40M derived: sum of 3 quarters · filed 2024-08-13 | -$21.95M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | -$3.32M 10-Q · filed 2024-06-17 | -$10.59M derived: sum of 2 quarters · filed 2024-06-17 | -$17.14M derived: sum of 3 quarters · filed 2024-06-17 | -$26.22M derived: sum of 4 quarters · filed 2024-06-17 |
| 2022-12-31 | -$7.28M derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-06 | -$13.82M derived: sum of 2 quarters · filed 2024-06-06 | -$22.90M derived: sum of 3 quarters · filed 2024-06-06 | -$35.66M 10-K · filed 2024-06-06 |
| 2022-09-30 | -$6.55M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2024-05-16 | -$15.63M derived: sum of 2 quarters · filed 2024-06-06 | -$28.38M 10-Q · filed 2024-05-16 | -$42.18M derived: sum of 4 quarters · filed 2024-06-06 |
| 2022-06-30 | -$9.08M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2024-06-06 | -$21.83M 10-Q/A · filed 2024-06-06 | -$35.63M derived: sum of 3 quarters · filed 2024-06-06 | -$30.77M derived: sum of 4 quarters · filed 2024-06-06 |
| 2022-03-31 | -$12.76M 10-Q/A · filed 2024-06-06 | -$26.55M derived: sum of 2 quarters · filed 2024-06-06 | -$21.69M derived: sum of 3 quarters · filed 2024-06-06 | -$32.77M derived: sum of 4 quarters · filed 2024-06-06 |
| 2021-12-31 | -$13.80M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | -$8.93M derived: sum of 2 quarters · filed 2023-03-27 | -$20.01M derived: sum of 3 quarters · filed 2023-03-27 | -$34.82M 10-K · filed 2023-03-27 |
| 2021-09-30 | $4.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$6.21M derived: sum of 2 quarters · filed 2022-11-14 | -$21.02M 10-Q · filed 2022-11-14 | -$32.83M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | -$11.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$25.89M 10-Q · filed 2022-08-15 | -$37.69M derived: sum of 3 quarters · filed 2022-08-15 | -$46.34M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | -$14.81M 10-Q · filed 2022-05-16 | -$26.62M derived: sum of 2 quarters · filed 2022-05-16 | -$35.27M derived: sum of 3 quarters · filed 2022-05-16 | -$46.23M derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | -$11.81M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-25 | -$20.46M derived: sum of 2 quarters · filed 2022-03-25 | -$31.42M derived: sum of 3 quarters · filed 2022-03-25 | -$39.27M 10-K · filed 2022-03-25 |
| 2020-09-30 | -$8.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-19 | -$19.62M derived: sum of 2 quarters · filed 2021-11-19 | -$27.46M 10-Q · filed 2021-11-19 | -$12.13M derived: sum of 4 quarters · filed 2021-11-19 |
| 2020-06-30 | -$10.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$18.81M 10-Q · filed 2021-08-12 | -$3.48M derived: sum of 3 quarters · filed 2021-08-12 | -$8.50M derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | -$7.85M 10-Q · filed 2021-05-12 | $7.48M derived: sum of 2 quarters · filed 2021-05-12 | $2.47M derived: sum of 3 quarters · filed 2021-05-12 | -$2.52M derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | $15.33M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $10.31M derived: sum of 2 quarters · filed 2021-03-11 | $5.33M derived: sum of 3 quarters · filed 2021-03-11 | $1.32M 10-K · filed 2021-03-11 |
| 2019-09-30 | -$5.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$10.00M derived: sum of 2 quarters · filed 2020-11-12 | -$14.01M 10-Q · filed 2020-11-12 | -$19.98M derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | -$4.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | -$9.00M 10-Q · filed 2020-08-12 | -$14.96M derived: sum of 3 quarters · filed 2020-08-12 | -$19.15M derived: sum of 4 quarters · filed 2020-08-12 |
| 2019-03-31 | -$4.01M 10-Q · filed 2020-05-14 | -$9.97M derived: sum of 2 quarters · filed 2020-05-14 | -$14.17M derived: sum of 3 quarters · filed 2020-05-14 | -$18.85M derived: sum of 4 quarters · filed 2020-05-14 |
| 2018-12-31 | -$5.96M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | -$10.16M derived: sum of 2 quarters · filed 2020-03-10 | -$14.84M derived: sum of 3 quarters · filed 2020-03-10 | -$19.49M 10-K · filed 2020-03-10 |
| 2018-09-30 | -$4.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$8.88M derived: sum of 2 quarters · filed 2019-11-07 | -$13.52M 10-Q · filed 2019-11-07 | -$18.87M derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | -$4.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$9.33M 10-Q · filed 2019-08-08 | -$14.67M derived: sum of 3 quarters · filed 2019-09-23 | -$18.67M derived: sum of 4 quarters · filed 2019-09-23 |
| 2018-03-31 | -$4.65M 10-Q · filed 2019-05-08 | -$9.99M derived: sum of 2 quarters · filed 2019-09-23 | -$13.99M derived: sum of 3 quarters · filed 2019-09-23 | |
| 2017-12-31 | -$5.34M derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-09-23 | -$9.34M derived: sum of 2 quarters · filed 2019-09-23 | -$19.79M 10-K/A · filed 2019-09-23 | |
| 2017-09-30 | -$4.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | -$14.45M 10-Q · filed 2018-11-06 | ||
| 2017-08-31 | -$11.90K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-09-12 | -$23.23K 10-Q · filed 2017-09-12 | ||
| 2017-06-30 | -$3.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | -$10.45M 10-Q · filed 2018-08-06 | ||
| 2017-05-31 | -$11.33K 10-Q · filed 2017-07-11 | |||
| 2017-03-31 | -$7.00M 10-Q · filed 2018-05-15 | -$1.37M derived: sum of 2 quarters · filed 2018-05-15 | ||
| 2016-12-31 | $5.63M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | -$5.05M 10-K · filed 2018-03-09 | ||
| 2016-09-30 | -$10.68M 10-Q · filed 2017-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |